107 related articles for article (PubMed ID: 1643743)
1. Effect of pharmacological purging on natural killer cell number and activity in human bone marrow.
Cardoso AA; Fallon M; Mukherji B; Silva MR; Marusic M; Gaffney J; Ascensao JL
Clin Immunol Immunopathol; 1992 Aug; 64(2):106-11. PubMed ID: 1643743
[TBL] [Abstract][Full Text] [Related]
2. Generation of human natural killer cells from pharmacologically purged bone marrow.
Silva MR; Ascensao JL
Br J Haematol; 1995 Jan; 89(1):34-40. PubMed ID: 7833274
[TBL] [Abstract][Full Text] [Related]
3. Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
Vaz F; Silva MR; Ascensao JL
Br J Cancer; 1995 Dec; 72(6):1498-503. PubMed ID: 8519666
[TBL] [Abstract][Full Text] [Related]
4. ASTA-Z 7557 impairs human natural killer (NK) cell activity.
Condiotti R; Slavin S; Nagler A
Leuk Res; 1996 Feb; 20(2):169-74. PubMed ID: 8628016
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging.
Zhong RK; Donnenberg AD; Rubin J; Ball ED
Blood; 1994 Apr; 83(8):2345-51. PubMed ID: 7512845
[TBL] [Abstract][Full Text] [Related]
7. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ
Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582
[TBL] [Abstract][Full Text] [Related]
9. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
10. Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation.
Jones RJ; Zuehlsdorf M; Rowley SD; Hilton J; Santos GW; Sensenbrenner LL; Colvin OM
Blood; 1987 Nov; 70(5):1490-4. PubMed ID: 3311205
[TBL] [Abstract][Full Text] [Related]
11. Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
Frondoza CG; Sinha S; Trivedi SM; Humphrey RL; Colvin OM
Exp Hematol; 1987 Jul; 15(6):715-8. PubMed ID: 3297761
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.
Charak BS; Malloy B; Agah R; Mazumder A
Bone Marrow Transplant; 1990 Sep; 6(3):193-8. PubMed ID: 2252959
[TBL] [Abstract][Full Text] [Related]
13. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
15. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
Abrams SI; Brahmi Z
Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
[TBL] [Abstract][Full Text] [Related]
16. Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells.
Ayroldi E; Cannarile L; D'Adamio F; Delfino D; Migliorati G; Riccardi C
Nat Immun; 1992; 11(6):317-27. PubMed ID: 1477494
[TBL] [Abstract][Full Text] [Related]
17. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E; Savary CA
Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
[TBL] [Abstract][Full Text] [Related]
19. Effect of Biostim (RU 41.740) on natural killer cell generation from bone marrow precursors.
Migliorati G; Guidi G; Cannarile L; Riccardi C
Int J Immunopharmacol; 1989; 11(1):77-82. PubMed ID: 2565297
[TBL] [Abstract][Full Text] [Related]
20. A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
Rubin J; Malley V; Ball ED
J Hematother; 1994; 3(2):121-7. PubMed ID: 7922015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
